We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Draws Up Blueprint for Pre-Approval Facility Reviews
FDA Draws Up Blueprint for Pre-Approval Facility Reviews
The FDA outlined plans coordinating CDER and the Office of Regulatory Affairs in inspecting manufacturing facilities seeking approval for new pharmaceuticals.